The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Hims and Roman are telehealth companies that sell prescription and nonprescription products to treat erectile dysfunction (ED), hair loss, and premature ejaculation (PE). Both ED and hair loss can ...